Genetic polymorphisms of CYP2C8 and phenotypic variability in atorvastatin-associated myopathy.
To define the phenotypic variability of atorvastatin-induced myopathy, we analysed the relation of CYP2C8 genotype to symptoms and to enzymes (CYP2C8*3, CYP2C8*4) and metabolites (succinate, 4-hydroxyatorvastatin) quantified in 50e0806aeb osrywel
https://www.pteridoportal.org/....portal/checklists/ch
https://kasujjaelizabeth.com/h....tml-to-php-converter
Like
Comment
Share
